TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9331007

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 2 mg
Number of subjects: 1482

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 4 mg
Number of subjects: 1482

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 8 mg
Number of subjects: 1482

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 16 mg
Number of subjects: 1482

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1482
Study: 8488994

Group type: EXPERIMENTAL
Intervention: 150 mg amiphenazole
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 3547126

Group type: EXPERIMENTAL
Intervention: Cyclosporine (6 mg per kilogram of body weight per day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30741813

Group type: EXPERIMENTAL
Intervention: IV acetaminophen (1,000 mg)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo (preoperative saline)
Number of subjects: 204
Study: 29217001

Group type: EXPERIMENTAL
Intervention: Platinum-chromium everolimus-eluting stent (PtCr-EES)
Number of subjects: 1530

Group type: COMPARATOR
Intervention: Cobalt-chromium everolimus-eluting stent (CoCr-EES)
Number of subjects: 1530

Group type: EXPERIMENTAL
Intervention: Platinum-chromium everolimus-eluting stent (PtCr-EES) in small vessels
Number of subjects: 1530

Group type: EXPERIMENTAL
Intervention: Platinum-chromium everolimus-eluting stent (PtCr-EES) in long lesions
Number of subjects: 1530
Study: 26293644

Group type: EXPERIMENTAL
Intervention: Web-delivered TES intervention
Number of subjects: 141

Group type: COMPARATOR
Intervention: Traditional intervention delivered by a prevention specialist
Number of subjects: 141
Study: 24309584

Group type: EXPERIMENTAL
Intervention: Daily language rehabilitation for 2 weeks (starting 2.2 days poststroke)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No rehabilitation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Daily language rehabilitation
Number of subjects: 12
Study: 22951346

Group type: EXPERIMENTAL
Intervention: Electrically Heated Cigarette Smoking System (EHCSS) and EHCSS‐K3 cigarette (3mg tar, 0.2mg nicotine, and 0.6 mg CO)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: No smoking
Number of subjects: 72

Group type: COMPARATOR
Intervention: Lark One cigarettes
Number of subjects: 72
Study: 19567902

Group type: EXPERIMENTAL
Intervention: High-fidelity assertive community treatment (ACT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care from community mental health teams
Number of subjects: 0
Study: 17550442

Group type: EXPERIMENTAL
Intervention: CO2 laser treatment
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Both laser treatments
Number of subjects: 10
Study: 16252540

Group type: EXPERIMENTAL
Intervention: Single-bottle adhesive system with compomer
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Single-bottle adhesive system with packable composite
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Single-bottle adhesive system with amalgam
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Single-bottle adhesive system with all materials
Number of subjects: 36
Study: 12197375

Group type: EXPERIMENTAL
Intervention: Active labour
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (not in labour)
Number of subjects: 40
Study: 10362451

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (CR, 5 g creatine monohydrate + 3 g dextrose)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (CR)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo supplementation (PLA, 7 g dextrose)
Number of subjects: 10
Study: 7780117

Group type: EXPERIMENTAL
Intervention: Femoral neck fracture group
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Intertrochanteric fracture group
Number of subjects: 102

Group type: COMPARATOR
Intervention: Normal control group
Number of subjects: 102
Study: 2180536

Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (Saline)
Number of subjects: 56
Study: 94528

Group type: EXPERIMENTAL
Intervention: Dextranomer beads
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline dressings
Number of subjects: 0
Study: 29064315

Group type: EXPERIMENTAL
Intervention: Trichuris suis (TSO) treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Baseline versus treatment (BVT) control
Number of subjects: 16
Study: 26608038

Group type: EXPERIMENTAL
Intervention: Exercise-based Brain-Gym concept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 25730417

Group type: EXPERIMENTAL
Intervention: Financial incentives delivered contingent on smoking abstinence
Number of subjects: 236

Group type: COMPARATOR
Intervention: Control condition (incentives delivered independent of smoking status)
Number of subjects: 236
Study: 23645837

Group type: EXPERIMENTAL
Intervention: Patients with VT
Number of subjects: 4480

Group type: COMPARATOR
Intervention: Partner controls
Number of subjects: 4480

Group type: COMPARATOR
Intervention: RDD controls
Number of subjects: 4480
Study: 21291510

Group type: EXPERIMENTAL
Intervention: Trans-obturator tape (TOT)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 194
Study: 19821873

Group type: EXPERIMENTAL
Intervention: Physiotherapy plus caregiver education in rehabilitation (strategy 1, S1)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Education alone (strategy 2, S2)
Number of subjects: 110
Study: 17010306

Group type: EXPERIMENTAL
Intervention: Guided self-help (GSH)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Pure self-help (PSH)
Number of subjects: 49
Study: 14764173

Group type: EXPERIMENTAL
Intervention: Step-down method
Number of subjects: 44

Group type: COMPARATOR
Intervention: Binary search method
Number of subjects: 44
Study: 12040348

Group type: EXPERIMENTAL
Intervention: Angiotensinogen M235T genotype in hypertensive patients
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Angiotensinogen M235T genotype in normotensive patients
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: Angiotensinogen gene variation
Number of subjects: 605
Study: 9734653

Group type: EXPERIMENTAL
Intervention: Quinine (30 mg/kg/d)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control (no quinine)
Number of subjects: 131
Study: 7983237

Group type: EXPERIMENTAL
Intervention: Single doses of NM441 (20, 50, 100, 200, and 400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple doses of NM441 (300 mg twice daily for 6.5 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single doses of NM441 (100, 200, and 400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single doses of NM441 (400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single doses of NM441
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple doses of NM441
Number of subjects: 0
Study: 2648779

Group type: EXPERIMENTAL
Intervention: Patients with all three risk characteristics (no history of previous angina or myocardial infarction, ST segment elevation or signs of Q wave development, peak MB-creatine kinase value ≥ 150 IU/L)
Number of subjects: 849

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 849
Study: 773016

Group type: EXPERIMENTAL
Intervention: Oral estrogen Quinestrol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Injected drug
Number of subjects: 0
Study: 31955207

Group type: EXPERIMENTAL
Intervention: History of pregnancy and infertility (n = 147)
Number of subjects: 2085

Group type: EXPERIMENTAL
Intervention: History of pregnancy without infertility (n = 736)
Number of subjects: 2085

Group type: COMPARATOR
Intervention: Nulligravid women without infertility (n = 173)
Number of subjects: 2085

Group type: EXPERIMENTAL
Intervention: Nulligravid women with histories of infertility (n = 19)
Number of subjects: 2085

Group type: EXPERIMENTAL
Intervention: Postmenopausal women (n = 1010)
Number of subjects: 2085

Group type: EXPERIMENTAL
Intervention: Infertility or pregnancy
Number of subjects: 2085
Study: 31004346

Group type: COMPARATOR
Intervention: ACT-709478 (1-400 mg)
Number of subjects: 65

Group type: COMPARATOR
Intervention: ACT-709478 (60 mg)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 29135373

Group type: EXPERIMENTAL
Intervention: Silymarin 1,050 mg/day
Number of subjects: 62

Group type: COMPARATOR
Intervention: Silymarin 420 mg/day
Number of subjects: 62
Study: 26653096

Group type: EXPERIMENTAL
Intervention: Video laryngoscopy
Number of subjects: 809

Group type: COMPARATOR
Intervention: Direct laryngoscopy
Number of subjects: 809
Study: 22753022

Group type: EXPERIMENTAL
Intervention: rhTPO + danazol
Number of subjects: 140

Group type: COMPARATOR
Intervention: danazol
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: rhTPO (given to control group patients in second phase)
Number of subjects: 140
Study: 20035173

Group type: EXPERIMENTAL
Intervention: Quadricortical syndesmotic screw fixation (n = 23)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Tricortical syndesmotic screw fixation (n = 25)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Obese patients (BMI > 30 kg/m2)
Number of subjects: 48
Study: 18773994

Group type: EXPERIMENTAL
Intervention: Baseline cardiopulmonary exercise test 1
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Baseline cardiopulmonary exercise test 2
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Within-subject absolute change in pVo2
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Other parameters (ventilation-to-carbon-dioxide production slope, Vo2 at ventilatory threshold)
Number of subjects: 398
Study: 15975107

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study: 14571350

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER (75 mg, could be increased to 150 mg)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Amitriptyline ER (75 mg, could be increased to 150 mg)
Number of subjects: 160
Study: 10500015

Group type: EXPERIMENTAL
Intervention: 5-day protein-free diet
Number of subjects: 11

Group type: COMPARATOR
Intervention: 5-day diet providing adequate nitrogen and amino acids except for sulfur amino acids (SAAs) or leucine
Number of subjects: 11
Study: 8943593

Group type: EXPERIMENTAL
Intervention: Codeine phosphate 60 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Morphine sulphate 10 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no analgesia)
Number of subjects: 40
Study: 1816937

Group type: EXPERIMENTAL
Intervention: Tympanic cavity wash tubes (grommets) inserted (26%) or myringotomy (10%) after persistence of middle ear effusions for more than 3 months
Number of subjects: 184

Group type: COMPARATOR
Intervention: Grommets inserted as a primary treatment
Number of subjects: 184
Study: 6220335

Group type: EXPERIMENTAL
Intervention: Duxil
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 30742868

Group type: EXPERIMENTAL
Intervention: LCAG secured with autogenous serum in-situ
Number of subjects: 60

Group type: COMPARATOR
Intervention: LCAG secured with sutures
Number of subjects: 60
Study: 27543915

Group type: COMPARATOR
Intervention: Cognitive-behavioral intervention (control condition)
Number of subjects: 108
Study: 27524691

Group type: EXPERIMENTAL
Intervention: Forearm blocks (ultrasound-guided median, ulnar, and radial nerve blocks at the mid to proximal forearm)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Brachial plexus blocks (ultrasound-guided supraclavicular, infraclavicular, or axillary nerve block)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Forearm blocks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Brachial plexus blocks
Number of subjects: 60
Study: 24275098

Group type: COMPARATOR
Intervention: Dolutegravir 50 mg as a tablet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg in 10 g of granule administered directly to mouth
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg in 10 g of granule mixed with purified water
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg in 10 g of granule mixed with water containing high cation concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg in 10 g of granule mixed with milk-based infant formula
Number of subjects: 0
Study: 21904859

Group type: EXPERIMENTAL
Intervention: Ethylene oxide (EO) gas sterilization
Number of subjects: 70

Group type: COMPARATOR
Intervention: Autoclaving
Number of subjects: 70
Study: 19653268

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 829

Group type: COMPARATOR
Intervention: No Prednisolone
Number of subjects: 829
Study: 16815036

Group type: EXPERIMENTAL
Intervention: Conceptual problem-solving task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal intelligence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Processing style
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implicit knowledge
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Personality measures
Number of subjects: 0
Study: 16313289

Group type: EXPERIMENTAL
Intervention: Indinavir
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Zidovudine and Lamivudine
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Zidovudine, Lamivudine and Indinavir
Number of subjects: 175
Study: 15592220

Group type: EXPERIMENTAL
Intervention: Transbond Plus (3M/ Unitek)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: First Step (Reliance Orthodontic Products)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Transbond XT (3M/ Unitek)
Number of subjects: 270
Study: 10989902

Group type: EXPERIMENTAL
Intervention: Laparoscopic skills training using simulated tasks on a video-trainer for 30 minutes daily for 10 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: No formal training (Control group)
Number of subjects: 27
Study: 8772687

Group type: EXPERIMENTAL
Intervention: Metoprolol (n = 40)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo (n = 37)
Number of subjects: 77
Study: 1463596

Group type: EXPERIMENTAL
Intervention: 70 mg/Kg/die of reduced glutathione (GSH)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 40
Study: 6531440

Group type: EXPERIMENTAL
Intervention: Apomorphine HCl (0.25, 0.5 or 0.75 mg sc)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Benztropine (2 mg iv)
Number of subjects: 9
Study: 31842106

Group type: EXPERIMENTAL
Intervention: Supervised physical therapy twice a week (P2 group)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Supervised physical therapy once a week (P1 group)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Home exercise program alone (HE group)
Number of subjects: 124
Study: 31136089

Group type: EXPERIMENTAL
Intervention: CART analysis predicting plan quality
Number of subjects: 200
Study: 28447362

Group type: EXPERIMENTAL
Intervention: 595-nm pulsed dye laser (PDL) treatment (fluence 8 J/cm3, pulse duration 10 ms, spot size 7 mm, 2 sessions every 2 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 595-nm pulsed dye laser (PDL) treatment
Number of subjects: 30
Study: 25861793

Group type: EXPERIMENTAL
Intervention: Photographic art in exam rooms
Number of subjects: 117

Group type: COMPARATOR
Intervention: Standard medical posters (control room)
Number of subjects: 117
Study: 23561694

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 8.75 mg microgranules
Number of subjects: 373

Group type: COMPARATOR
Intervention: Placebo microgranules
Number of subjects: 373
Study: 21168109

Group type: EXPERIMENTAL
Intervention: Traditional Chinese acupuncture (TCA) weekly for 5 weeks
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Attention only (practitioner present and participant supine) weekly for 5 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 18
Study: 19063649

Group type: EXPERIMENTAL
Intervention: Established guidelines plus the DASH diet (increased fruits, vegetables, low-fat dairy, reduced fat)
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Established guidelines for blood pressure control (reduced sodium, increased physical activity)
Number of subjects: 810

Group type: COMPARATOR
Intervention: Advice‐Only
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Established plus DASH
Number of subjects: 810
Study: 17928991

Group type: EXPERIMENTAL
Intervention: Urate oxidase (1.5 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15110879

Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy followed by myeloablative chemotherapy and autologous stem-cell rescue
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intensive chemotherapy alone
Number of subjects: 0
Study: 11241729

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 34

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 34
Study: 9206638

Group type: EXPERIMENTAL
Intervention: Topical decontamination with polymyxin B, tobramycin, vancomycin and amphotericin B, and perioperative i.v. prophylaxis with cefotaxim from the day before surgery until the 7th postoperative day
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Topical decontamination with polymyxin B, tobramycin, vancomycin and amphotericin B, and perioperative i.v. prophylaxis with cefotaxim
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 7959618

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH), 0.1 IU/kg/day 6 days/week for 3 years (Group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Growth hormone (GH) and gonadotropin-releasing hormone agonist for the first 2 years (Group B)
Number of subjects: 30
Study: 3318430

Group type: EXPERIMENTAL
Intervention: Nabumetone 1,000 mg given at bedtime
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naproxen 250 mg given twice daily
Number of subjects: 0
Study: 31396625

Group type: EXPERIMENTAL
Intervention: EPA + DHA supplementation, mean dosage 1983 ± 1297 mg/d, duration 13.6 ± 6.0 weeks
Number of subjects: 1422

Group type: COMPARATOR
Intervention: Placebo control, n = 576, took none
Number of subjects: 1422
Study: 28289931

Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg twice daily)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 26357944

Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg twice daily
Number of subjects: 411

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 411
Study: 22585012

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) program for 8 weeks
Number of subjects: 146

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 146
Study: 21404174

Group type: EXPERIMENTAL
Intervention: MiniScan (test group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clinical judgement (control group)
Number of subjects: 0
Study: 19392943

Group type: EXPERIMENTAL
Intervention: Swedish alcohol salespersons
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control persons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Male participants
Number of subjects: 0
Study: 17037893

Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond (Kuraray)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Xeno III (Dentsply)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: G Bond (GC)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: One-Up Bond F (Tokuyama)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Wire method
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Blade method
Number of subjects: 119
Study: 15287927

Group type: EXPERIMENTAL
Intervention: Nateglinide monotherapy (120 mg before meals) in group 1 (diet alone or low-dose sulfonylureas)
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Nateglinide as add-on therapy (120 mg before meals) in group 2 (steady dose of metformin)
Number of subjects: 358
Study: 12750554

Group type: EXPERIMENTAL
Intervention: Autologous hemoderivative vaccination
Number of subjects: 28
Study: 11149499

Group type: EXPERIMENTAL
Intervention: Hip fracture patients (both osteosynthesis and hemiarthroplasty)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Osteosynthesis group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Age-matched controls without hip fractures
Number of subjects: 24
Study: 8795327

Group type: EXPERIMENTAL
Intervention: Piroxicam (Feldene 'Melt')
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diclofenac suppositories
Number of subjects: 0
Study: 1505903

Group type: EXPERIMENTAL
Intervention: Human growth hormone (4 IU daily)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Total parenteral nutrition (PN)
Number of subjects: 38
Study: 6571404

Group type: EXPERIMENTAL
Intervention: Muscle discrimination training during a headache treatment program that included standard behavioral procedures.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Conventional program (control group).
Number of subjects: 38
Study: 30690638

Group type: EXPERIMENTAL
Intervention: Potent D2 antagonists
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control group (not taking potent D2 antagonists)
Number of subjects: 184
Study: 28976540

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention for 9 months
Number of subjects: 308

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 308
Study: 26334710

Group type: EXPERIMENTAL
Intervention: Higher school engagement at ages 12 and 14
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: More alcohol consumption at ages 12 and 14
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Higher school engagement at age 13
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Alcohol use at age 13
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: High parental support
Number of subjects: 906
Study: 24698971

Group type: EXPERIMENTAL
Intervention: ICD with PFO monitoring (diagnostics group)
Number of subjects: 221

Group type: COMPARATOR
Intervention: ICD without PFO monitoring (control group)
Number of subjects: 221
Study: 23147973

Group type: EXPERIMENTAL
Intervention: Better housing quality (measured by passing housing quality items)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Substandard housing (baseline condition)
Number of subjects: 246
Study: 20638231

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA) using ClosurePlus system
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Endovenous laser treatment (EVL) using EVLT system
Number of subjects: 118